STOCKSCREENR

0GP7.L

LSE

Medivir AB (publ)

$1.84-0.15(-7.35%)Mkt Cap: $210.19M

Key Stats

Market Cap

$210.19M

P/E Ratio

-1.16

EPS

$-1.58

Dividend Yield

0.00%

52-Week Range

$1.84 — $7.38

Volume

31.35K

Avg Volume

2.33K

Beta

0.24

Price Alerts for 0GP7.L

Get alerted when 0GP7.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-1.16

Forward P/E

—

PEG Ratio

-0.25

P/S (TTM)

91.27

P/B (TTM)

2.09

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.38%

ROA (TTM)

-0.38%

ROIC

—

Gross Margin

-14.67%

Operating Margin

-19.82%

Net Margin

—

Debt/Equity

0.08

Current Ratio

4.39

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.16%

EPS Growth (5Y)

+0.25%

Sales Growth (3Y)

+0.20%

Sales Growth (5Y)

-0.08%

EPS Est (This Year)

$-1.22

EPS Est (Next Year)

$-1.97

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$2.11

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

114.24M

Float

87.15M

Free Float %

76.29%

Technicals

RSI (14)

77.74

SMA 20

$0.52

SMA 50

$0.85

SMA 200

$0.85

ATR (14)

0.05

Volatility (Week)

0.18%

Volatility (Month)

0.13%

Pattern

—

Performance

1 Day

+5.29%

1 Week

+74.75%

1 Month

+64.68%

3 Months

—

6 Months

—

1 Year

—

YTD

+94.51%

All-Time High

$2.91

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

SE

Exchange

LSE

IPO Date

2023-06-07

Employees

10

CEO

Jens Lindberg

Index Membership

—

Website

https://www.medivir.com

Medivir AB (publ) (0GP7.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $210.19M, a P/E ratio of -1.16, 0GP7.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0GP7.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

ATAI

Atai Beckley N.V

$4.16

+0.97%

$784.68M

0DOL.L

Biofrontera AG

$2.50

+1.63%

$111.43M

LFMD

LifeMD, Inc.

$4.68

+5.64%

$224.52M

0RNK.L

Inventiva S.A.

$4.27

+1.67%

$593.11M

0LOV.L

Verastem, Inc.

$5.42

+2.07%

$328.12M

0DTF.L

Boiron S.A.

$26.10

-1.14%

$453.16M

Frequently Asked Questions

What is Medivir AB (publ)'s P/E ratio?

Medivir AB (publ) (0GP7.L) has a trailing twelve-month (TTM) P/E ratio of -1.16. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Medivir AB (publ) pay a dividend?

No, Medivir AB (publ) (0GP7.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Medivir AB (publ)'s market cap?

Medivir AB (publ) (0GP7.L) has a market capitalization of $210.19 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

How has 0GP7.L performed this year?

Medivir AB (publ) (0GP7.L) has returned +94.51% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.